Back HIV/AIDS

HIV / AIDS

Not Enough Is Being Done to Provide Universal Access to HIV Treatment, Advocates Say

An international coalition of AIDS treatment advocates, clinical providers, and people living with HIV has released an analysis showing than fewer than 1 in 10 people with HIV live in countries that provide antiretroviral therapy (ART) for all regardless of CD4 count, contrary to international treatment guidelines. The activists urged more funding to make global recommendations for universal treatment a reality.

alt

WHO Issues Recommendations on Linkage to Care, Retention to Help Bring HIV Treatment to All

The World Health Organization (WHO) has issued new recommendations on how to organize services in order to promote linkage to care and retention in care as part of its new guidelines recommending antiretroviral treatment for all adults and adolescents diagnosed with HIV.

alt

UNAIDS and WHO Highlight Fast-Track Efforts to Expand HIV Prevention and Treatment

In advance of World AIDS Day, UNAIDS and the World Health Organization (WHO) released new reports describing successful local efforts to reduce new HIV infections and get more people living with HIV on effective treatment. The global World AIDS Day theme for 2015 is the Fast-Track to ending the AIDS epidemic by 2030 as part of the United Nations Sustainable Development Goals.With progress to date exceeding expectations, world leaders are now calling for accelerated efforts to achieve more ambitious goals.

alt

Many More Could Benefit from HIV PrEP, But Not Enough Doctors Are Aware

One-quarter of gay and bisexual men in the U.S. and one-fifth of people who inject drugs, but less than 1% of heterosexual men and women, could benefit from Truvada pre-exposure prophylaxis or PrEP -- more than 1.2 million people in total -- according to a new Centers for Disease Control and Prevention (CDC) Vital Signs report released ahead of World AIDS Day. But a nationwide survey found that one-third of U.S. healthcare providers had not heard about PrEP, prompting the CDC to launch an expanded awareness effort.

alt

France Approves Truvada for HIV Pre-exposure Prophylaxis

In a historic move, France has become the first country outside the U.S., and the first country with a centrally organized, reimbursable health system, to approve no-expense pre-exposure prophylaxis (PrEP) for people who need it. The French Minister of Health, Marisol Touraine, announced on November 24 today that PrEP would be available starting in mid-December, and reimbursable through the French health system from the beginning of January.

alt

December 1 Is World AIDS Day

Tuesday, December 1, is World AIDS Day, an opportunity both to remember the millions of people worldwide who have been lost to the epidemic, and to address remaining gaps in HIV prevention, care, and treatment. The U.S. World AIDS Day theme, "The Time to Act is Now," and the global theme of getting on the Fast-Track to end the AIDS epidemic both underscore how the remarkable progress to date has spurred efforts to achieve more ambitious goals.

alt

Genvoya Pill with Tenofovir Alafenamide Added to Recommended HIV Regimens

The Department of Health and Human (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents has added the recently approved Genvoya single-tablet regimen containing elvitegravir and the new tenofovir alafenamide to its list of recommended regimens for initial HIV treatment.

alt